Publishing research using ab88247? Please let us know so that we can cite the reference in this datasheet.

ab88247 has been referenced in 1 publication.

  • Scialdone A  et al. The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo. Oncotarget 8:37409-37422 (2017). PubMed: 28445158

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up